Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jennifer Laudadio

Concepts (136)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Papillomavirus Infections
4
2015
159
1.350
Why?
Papillomaviridae
3
2015
106
1.020
Why?
Keratosis, Seborrheic
2
2015
4
0.670
Why?
Vulvar Diseases
2
2015
7
0.660
Why?
Alphapapillomavirus
2
2014
16
0.620
Why?
Pathology
1
2015
46
0.530
Why?
Fusion Proteins, bcr-abl
3
2009
22
0.530
Why?
Curriculum
2
2022
415
0.490
Why?
Uterine Cervical Dysplasia
1
2013
18
0.490
Why?
Neoplasm Invasiveness
2
2012
303
0.480
Why?
Genomics
1
2015
269
0.480
Why?
Cervical Intraepithelial Neoplasia
1
2013
42
0.480
Why?
Perineum
1
2012
24
0.450
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
2009
49
0.450
Why?
Myxoma
1
2012
14
0.450
Why?
Mutagenesis, Insertional
2
2008
27
0.430
Why?
Vulvar Neoplasms
1
2012
54
0.430
Why?
Uterine Cervical Neoplasms
1
2013
288
0.390
Why?
Mass Screening
1
2013
385
0.370
Why?
In Situ Hybridization, Fluorescence
2
2007
274
0.340
Why?
Introns
1
2008
49
0.340
Why?
Protein Kinase Inhibitors
2
2013
217
0.320
Why?
Genes, erbB-2
1
2007
8
0.320
Why?
Actinomyces
1
2006
9
0.310
Why?
Actinomycosis
1
2006
10
0.310
Why?
Carcinoma, Squamous Cell
1
2010
400
0.310
Why?
Vaginal Smears
1
2006
34
0.310
Why?
Head and Neck Neoplasms
1
2010
331
0.310
Why?
Carcinoma, Transitional Cell
1
2005
51
0.280
Why?
Urinary Bladder Neoplasms
1
2005
168
0.260
Why?
DNA, Viral
2
2014
152
0.220
Why?
Fellowships and Scholarships
1
2022
125
0.210
Why?
Humans
19
2022
53051
0.210
Why?
Polymerase Chain Reaction
2
2014
554
0.200
Why?
Female
12
2015
28985
0.170
Why?
Middle Aged
7
2014
13685
0.160
Why?
Breast Neoplasms
1
2007
1274
0.160
Why?
Gastrointestinal Neoplasms
1
2015
40
0.140
Why?
Prognosis
4
2015
2105
0.130
Why?
Mucositis
1
2014
10
0.130
Why?
Oropharyngeal Neoplasms
1
2014
14
0.130
Why?
Histocytochemistry
1
2014
45
0.130
Why?
Microscopy
1
2014
66
0.130
Why?
Quinazolines
1
2013
38
0.130
Why?
Human Papillomavirus DNA Tests
1
2013
2
0.120
Why?
Protein Structure, Tertiary
3
2009
303
0.120
Why?
Virology
1
2013
8
0.120
Why?
Bile Duct Diseases
1
2013
12
0.120
Why?
Molecular Diagnostic Techniques
1
2013
38
0.120
Why?
United States Food and Drug Administration
1
2013
98
0.120
Why?
Genotype
1
2014
637
0.110
Why?
Carcinoma, Non-Small-Cell Lung
1
2013
130
0.110
Why?
Phosphotransferases
2
2009
24
0.110
Why?
RNA, Messenger
2
2013
1276
0.110
Why?
Clinical Competence
1
2015
447
0.110
Why?
Piperazines
2
2009
125
0.110
Why?
Cholelithiasis
1
2011
14
0.110
Why?
Cholecystectomy, Laparoscopic
1
2011
26
0.110
Why?
Aged
5
2014
10476
0.110
Why?
In Situ Hybridization
1
2010
91
0.100
Why?
Pyrimidines
2
2009
199
0.100
Why?
Endosonography
1
2011
99
0.100
Why?
Smoking
1
2014
573
0.090
Why?
Algorithms
1
2013
738
0.090
Why?
HIV Infections
1
2013
391
0.090
Why?
Exons
1
2008
108
0.090
Why?
Lung Neoplasms
1
2013
599
0.080
Why?
Diagnosis, Differential
1
2012
1185
0.080
Why?
United States
2
2022
5102
0.080
Why?
DNA Mutational Analysis
1
2008
197
0.080
Why?
Proto-Oncogenes
1
2007
25
0.080
Why?
Adult
6
2022
14383
0.080
Why?
Gene Amplification
1
2007
59
0.080
Why?
Receptor, erbB-2
1
2007
84
0.080
Why?
Base Sequence
1
2008
756
0.080
Why?
Aged, 80 and over
3
2014
3642
0.080
Why?
Amino Acid Sequence
1
2008
808
0.070
Why?
Molecular Sequence Data
1
2008
1037
0.070
Why?
Cell Division
1
2007
370
0.070
Why?
Young Adult
2
2013
4310
0.070
Why?
Male
7
2014
28342
0.070
Why?
Immunohistochemistry
1
2007
1143
0.060
Why?
Retrospective Studies
4
2022
6079
0.060
Why?
Sensitivity and Specificity
1
2005
973
0.060
Why?
Disease-Free Survival
2
2014
522
0.060
Why?
Antineoplastic Agents
4
2014
1290
0.060
Why?
Mutation
1
2009
1432
0.060
Why?
Pathology, Molecular
1
2022
23
0.060
Why?
Adolescent
3
2011
6889
0.060
Why?
Accreditation
1
2022
70
0.060
Why?
Neoplasm Recurrence, Local
1
2005
597
0.050
Why?
Combined Modality Therapy
2
2014
713
0.050
Why?
Education, Medical, Graduate
1
2022
223
0.050
Why?
Benzamides
2
2009
51
0.050
Why?
Treatment Outcome
3
2014
5646
0.040
Why?
Molecular Imaging
1
2015
61
0.040
Why?
Cyclin D3
1
2013
6
0.030
Why?
Survival
1
2013
17
0.030
Why?
Taxoids
1
2013
46
0.030
Why?
Cyclin D1
1
2013
62
0.030
Why?
Granulocyte Colony-Stimulating Factor
1
2013
67
0.030
Why?
Anti-Retroviral Agents
1
2013
17
0.030
Why?
Liver Cirrhosis, Biliary
1
2013
12
0.030
Why?
Jaundice
1
2013
19
0.030
Why?
Polyethylene Glycols
1
2013
98
0.030
Why?
Radiotherapy
1
2014
158
0.030
Why?
Cholestasis
1
2013
41
0.030
Why?
Drug Administration Schedule
1
2013
428
0.030
Why?
Patient Compliance
1
2014
271
0.030
Why?
Syndrome
1
2013
260
0.030
Why?
Recombinant Proteins
1
2013
595
0.030
Why?
Technetium Tc 99m Lidofenin
1
2011
1
0.030
Why?
Ursodeoxycholic Acid
1
2011
3
0.030
Why?
Cholagogues and Choleretics
1
2011
4
0.030
Why?
Cholangiography
1
2011
11
0.030
Why?
Cholangiopancreatography, Magnetic Resonance
1
2011
8
0.030
Why?
False Negative Reactions
1
2011
38
0.030
Why?
Ceftriaxone
1
2011
31
0.030
Why?
CD4-Positive T-Lymphocytes
1
2013
189
0.030
Why?
Cisplatin
1
2013
348
0.030
Why?
Age of Onset
1
2011
121
0.030
Why?
Antibiotic Prophylaxis
1
2011
70
0.030
Why?
Radiography, Interventional
1
2011
69
0.020
Why?
Pancreatitis
1
2011
55
0.020
Why?
Biopsy
1
2013
698
0.020
Why?
Neurosurgical Procedures
1
2011
123
0.020
Why?
Gene Expression Regulation, Leukemic
1
2009
36
0.020
Why?
Comorbidity
1
2011
700
0.020
Why?
Up-Regulation
1
2009
538
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2013
1027
0.020
Why?
Transcription, Genetic
1
2008
465
0.020
Why?
Liver
1
2013
1263
0.020
Why?
Follow-Up Studies
1
2011
2452
0.020
Why?
Tomography, X-Ray Computed
1
2011
1296
0.020
Why?
Postoperative Complications
1
2011
1082
0.020
Why?
Child
1
2011
6942
0.010
Why?
Laudadio's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_